Recommendations
 
 
 
Asthma Research Results
A Survey and Questionnaire by Dr. Nyjon K. Eccles BSc MBBS PhD MRCP, The Chiron Clinic, 121 Harley Street & Jerry Yamoa, NHC Ltd.
  • 200 Questionaires sent out. 120 Returned. 60% Response.
  • Number of Asthma patients: 70
  • Mean duration of Asthma: 16.4 years
  • Age Range: 1 - 68 years
  • Male patients: 49%; Female patients: 41%; Gender unknown: 10%
  • 14 patients aged 1 - 29yrs; 40 patients aged 30 - 59yrs; 15 patients aged 60 - 89yrs



44% of patients who took part in the survey were Caucasian. 25% were African; 12% were Asian; 10% were Afro-Carribean and 9% were of undisclosed origin.
The reported number of attacks in one year experienced by the group before taking Yamoa was 78. Attacks dropped to 22 per year after Yamoa.

On average patients took some form of asthma medication 3.6 times a day before taking Yamoa Powder. The average number of times medication has been required on a daily basis since Yamoa has been taken is 1.7 times a day.

There were 3 hospital admissions amongst the group who responded to the survey before Yamoa was taken. Afterwards, there were none before the survey was completed.



The reported number of attacks in one year experienced by the group before taking Yamoa was 78. Attacks dropped to 22 per year after Yamoa.

On average patients took some form of asthma medication 3.6 times a day before taking Yamoa Powder. The average number of times medication has been required on a daily basis since Yamoa has been taken is 1.7 times a day.

There were 3 hospital admissions amongst the group who responded to the survey before Yamoa was taken. Afterwards, there were none before the survey was completed.


The average peak flow rate reading taken before Yamoa was 350. The average taken since using Yamoa Powder was 420. This means an average improvement of 70.

12% of patients found no benefits from taking Yamoa. 19% experienced a mild improvemnt in their condition. 29% reported a CURE. 40% reported a marked improvement in their condition.

Thus 69%, that is 69 people in every 100, experienced AT LEAST a marked improvement in their asthma as a result of taking Yamoa Powder.

Indications show that greater benefits may be achieved the younger the patient. This may be because the condition has not been with younger patients as long as for those in the older group; they may not have the history of stress and illness that older people have, in which case younger immune systems may be stronger than old. The younger group most likely does not have other contributing factors such as life-long smoking history etc.